Indu Lal
Impact in
- Genetics top 2%
- Chronic Lymphocytic Leukemia Research
- Hematology top 2%
- Hematopoietic Stem Cell Transplantation
- Chronic Myeloid Leukemia Treatments
Papers in
- Genetics 13
- Chronic Lymphocytic Leukemia Research 12
-
- Chronic Myeloid Leukemia Treatments 7
- Acute Myeloid Leukemia Research 5
- Co-authors
- Aaron C. Logan (4 shared papers)Samantha Jaglowski (4 shared papers)Lori Styles (4 shared papers)David B. Miklos (4 shared papers)Iskra Pusic (4 shared papers)Edmund K. Waller (4 shared papers)Mary E.D. Flowers (4 shared papers)Madan Jagasia (4 shared papers)
- Journals
- Blood (3 papers)Biology of Blood and Marrow Transplantation (2 papers)Leukemia Research (1 paper)Leukemia (1 paper)HemaSphere (1 paper)
- Partner nations
- United StatesUnited KingdomItaly
In The Last Decade
Indu Lal
14 papers receiving 776 citations
Hit Papers
Peers
Comparison fields: 5 of 46
- Genetics 518
- Hematology 372
- Pathology and Forensic Medicine 338
- Immunology 290
- Transplantation 24
Countries citing papers authored by Indu Lal
This map shows the geographic impact of Indu Lal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Indu Lal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Indu Lal more than expected).
Fields of papers citing papers by Indu Lal
This network shows the impact of papers produced by Indu Lal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Indu Lal. The network helps show where Indu Lal may publish in the future.
Co-authors
The 25 scholars most cited alongside Indu Lal, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Long-term efficacy and safety of first-line ibrutinib treatment for patients with CLL/SLL: 5 years of follow-up from the phase 3 RESONATE-2 study Hit paper breakdown → | 2019 | 312 |
| 2 | 2017 | 312 | |
| 3 | 2019 | 66 | |
| 4 | 2020 | 57 | |
| 5 | 2016 | 14 | |
| 6 | 2022 | 9 | |
| 7 | 2022 | 5 | |
| 8 | 2020 | 5 | |
| 9 | 2022 | 2 | |
| 10 | 2019 | 1 | |
| 11 | 2022 | 1 | |
| 12 | 2022 | 1 | |
| 13 | 2022 | 1 | |
| 14 | 2018 | 1 |
About Indu Lal
Indu Lal is a scholar working on Genetics, Hematology, Pathology and Forensic Medicine, Immunology and Public Health, Environmental and Occupational Health, having authored 14 papers that have together received 787 indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (12 papers), Chronic Myeloid Leukemia Treatments (7 papers), Lymphoma Diagnosis and Treatment (5 papers), Acute Myeloid Leukemia Research (5 papers), Immunodeficiency and Autoimmune Disorders (3 papers), Acute Lymphoblastic Leukemia research (3 papers), Phagocytosis and Immune Regulation (2 papers) and Gastrointestinal Tumor Research and Treatment (1 paper). The work is most often cited by research in Genetics (518 citations), Hematology (372 citations), Pathology and Forensic Medicine (338 citations), Immunology (290 citations) and Transplantation (24 citations). Indu Lal has collaborated with scholars based in United States, United Kingdom and Italy. Frequent co-authors include Aaron C. Logan, Samantha Jaglowski, Lori Styles, David B. Miklos, Iskra Pusic, Edmund K. Waller, Mary E.D. Flowers, Madan Jagasia, Mukta Arora and Corey Cutler. Their work appears in journals such as Blood, Biology of Blood and Marrow Transplantation, Leukemia Research, Leukemia and HemaSphere.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.